D.E. Shaw & Co
GEVA

D.E. Shaw & Co’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

D.E. Shaw & Co’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,000
Closed -$1.95M – 4025
2015
Q1 		$1.95M Buy
+20,000
New +$2.12M ﹤0.01% 2034

D.E. Shaw & Co's GEVA Position: Q2 2015 in Review

D.E. Shaw & Co sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 50,303 shares — an estimated $4.91M sold.

D.E. Shaw & Co first reported a position in GEVA in Q1 2014 and held it in 4 quarters. The position peaked at $6.64M in Q1 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • D.E. Shaw & Co reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 50,303 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $4.91M.
  • D.E. Shaw & Co first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 4 quarters.
  • D.E. Shaw & Co's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $6.64M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.